Newtree
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Newtree develops and distributes health-functional foods and ingredient materials designed to support skin health, body-fat management, and joint care, products it markets under the broad category of 'inner beauty', meaning beauty and wellness supported from within through nutrition.
Its finished products, which include skin-care supplements, diet foods, superfoods, and functional supplements, reach consumers through home-shopping channels, online platforms, and offline retail. Listed on KOSDAQ, Korea's tech and small-cap board, the company's product range centres on two proprietary ingredient brands: a low-molecular collagen peptide line and a fingerroot-plant extract, both of which have received functional-food recognition from Korea's food and drug safety authority.
Summary is AI-generated and may contain errors · figures from DART filings
Newtree holds individually recognised functional-food approvals from Korea's Ministry of Food and Drug Safety, a regulatory designation that distinguishes certified health claims from ordinary food labelling in Korea.
Newtree in five facts
What does Newtree do?
Newtree develops and distributes health-functional foods and ingredient materials designed to support skin health, body-fat management, and joint care, products it markets under the broad category of 'inner beauty', meaning beauty and wellness supported from within through nutrition.
Where is Newtree listed and in which sector?
Newtree (Korean name: 뉴트리) trades under KRX code 270870 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Consumer Staples sector, Food & Beverage.
How large is Newtree?
Its market capitalisation was US$23.8M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Newtree's latest annual revenue and operating profit?
For fiscal year 2025, Newtree reported revenue of US$76.3M, an operating loss of US$1.7M and a net loss of US$1.9M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was down 17.1% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Treasury share trust terminated: results reportSep 10
- Treasury share acquisition via trust: status reportSep 10
- Cash/in-kind dividend decision
Newtree declared a cash dividend of US$0.30 per share, equal to about 10.6% of the recent share price.
Dividend · Apr 3 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Newtree reported consolidated results for FY2025: revenue of US$70M (−16.92% year on year), an operating loss of US$1.38M (from a profit a year earlier) and a net loss of US$1.65M (from a profit a year earlier).
Earnings · Feb 20